Biohaven Therapeutics Ltd.

This study checks the long-term safety of the drug BHV-7000 in 660 adults whose focal epilepsy does not respond to current treatments. Participants have already completed an earlier study of the same drug. The main goal is to see how many people have serious side effects or need …

This study looks at whether the drug troriluzole can slow down spinocerebellar ataxia (SCA), a rare brain disease that affects movement and balance. About 900 people with SCA who took troriluzole for up to 3 years are compared to a group of untreated patients from a natural histo…

This study tests an investigational drug called taldefgrobep alfa to see if it helps adults with overweight or obesity lose weight. About 150 participants will receive either the drug or a placebo by injection for 24 weeks, with an option to continue in an open-label extension. T…

This early-stage study tests whether BHV-7000 can reduce chronic pain in people with inherited erythromelalgia, a rare genetic condition causing severe burning pain. Only 5 adults with a specific gene mutation will take part, receiving both the drug and a placebo at different tim…